Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

NCT01507545 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

154

Enrollment

INDUSTRY

Sponsor class

Stopped By the sponsor at the end of Stage 1 due to futility.

Conditions

Metastatic Colorectal Cancer
Colorectal Cancer

Interventions

DRUG: MORAb-004
DRUG: Placebo
OTHER: Best supportive care

Sponsor

Morphotek